Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$6.14 - $10.1 $341,138 - $561,156
-55,560 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.04 - $14.19 $502,262 - $788,396
55,560 New
55,560 $561,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $349M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Governors Lane LP Portfolio

Follow Governors Lane LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

News

Stay updated on Governors Lane LP with notifications on news.